News and Announcements
Author-IT Finalizes $13.5m NZ Series C Funding & Releases DocuveraTM
- Published August 04, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Author-it is a fast growing SaaS business that provides cloud based, authoring and content management solutions, purpose-built for the life sciences industry where documentation accounts for ~25% of the average cost of bringing a drug to market.
This past year was both successful and eventful for Author-it Software Corporation, a world leader in component authoring and content management solutions for the Life Sciences industry. The company finalized a $13.5m NZ Series C funding that had commenced earlier in 2016. In addition, Author-it formally released DocuveraTM in June 2017. Docuvera is a new transformative software platform used to create Life Science documentation for global companies. Docuvera dramatically increases compliance and lowers operating costs by 50%. Lastly, Author-it continued to sign new customers from the top tiers of global Life Sciences companies and add to its considerable and prestigious customer base.
ABOUT AUTHOR-IT
Author-it Software Corporation (ASC) is a world leader in component authoring solutions. We enable the efficient authoring, sharing and reuse of information across a number of content types. Reuse of information drives massive process and content production improvements including increased productivity, reduced time to market, better accuracy and consistency, improved customer experience and substantial cost savings. Author-it solutions have been built in partnership with our clients and are the culmination of more than 20 years component authoring experience.
Company Updates
The Index Approach in Early-Stage Venture Capital: Reconsidered
The venture capital (VC) landscape is marked by its dynamism and complexity, especially in early-stage investing. The traditional approach in VC, characterised by a selective and intensive vetting process, often contrasts with the concept of ‘index investing.’ This article revisits the indexing approach in early-stage VC, incorporating insights from recent studies and data, including a […]
The Future Is Now: The Evolution of Dealflow with Wholesale Investor
If you’ve ever thought of investing or expanding your portfolio, there’s no better time than the present. In the fast-paced world of investment, things are changing at a breathtaking speed, and it’s crucial to stay ahead of the game. The Future of Deal Flow is Today Dealflow, the lifeblood of the investment world, is not […]
Investability of a Startup: A Comprehensive Guide for Angels and High-Net Worth Investors
Venturing into the Startup Scene Let’s dive into the intriguing world of startups. It’s a thrilling ride, isn’t it? Like finding a pearl in an ocean, spotting a promising startup amidst a sea of businesses is no easy task. This guide aims to light the way, focusing on the “The Investability of a Startup: 7 […]
Backed By Leading Investment Groups and Family Offices
